Chamlion, the world’s first dental 3D printing service cloud platform will appear at the IDS
COLOGNE, Germany, March 9, 2023 /PRNewswire/ -- On March 14, Chamlion, a digital dental expert, will appear at the IDS in Germany, exhibiting the world's first dental 3D printing service cloud platform at booth K091 in Hall 11.3, providing one-stop solutions for global dental processing customers. Visiting Chamlion's booth will help people have a comprehensive understanding of our cloud platform,...
Medit Launches New Occlusion Analyzer App for Quick and Easy Analysis
SEOUL, South Korea and LONG BEACH, Calif., March 9, 2023 /PRNewswire/ -- Medit (www.medit.com), a leading provider of 3D intraoral scanners and digital dentistry solutions, announced today the release of its new app, the Medit Occlusion Analyzer.   The Medit Occlusion Analyzer is a powerful tool that allows dental...
Alnylam Pharmaceuticals and Medison Pharma Announce the Expansion of Their Collaboration to a Multi-Regional Partnership to Commercialize RNAi Therapeutics
ZUG, Switzerland, March 9, 2023 /PRNewswire/ -- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, and Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies for patients in international markets, have announced an expansion of their existing partnership to a multi-regional agreement that includes Poland, Czech Republic, Hungary,...
Waterdrop Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 17, 2023
BEIJING, March 9, 2023 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH) ("Waterdrop" or the "Company"), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2022, before U.S. markets open on Friday, March 17, 2023....
GenFleet Therapeutics to Present Phase I Data for GFH312 at 2023 American Society for Clinical Pharmacology & Therapeutics Meeting
SHANGHAI, March 9, 2023 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today announced the results from phase I study of GFH312 (RIPK1 inhibitor) monotherapy will be presented as a poster at the 2023 ASCPT Meeting in Atlanta on March 22nd. GFH312 is safe and well tolerated in healthy subjects in...
World-First, 45,000 patients study to develop AI-based “precision medicine” for migraine relief – collaboration between Healint and University of Geneva, Switzerland
PALO ALTO, Calif., March 9, 2023 /PRNewswire/ -- Healint, the developer and owner of Migraine Buddy – the world's largest migraine tracking and research platform used by more than 3 million people – is announcing a collaboration with the University of Geneva. Prof. Katarzyna Wac, Director...
NIPPON EXPRESS HOLDINGS Strengthens Pharmaceutical Logistics Quality System Globally
- Compiles "NX-Pharma Global Quality Manual" and Appoints Head of NX-Pharma Global Quality - TOKYO, March 9, 2023 /PRNewswire/ -- NIPPON EXPRESS HOLDINGS, INC., based in Tokyo, has compiled the NX-Pharma Global Quality Manual, applicable as of Sunday, January 1, 2023, to unify and standardize pharmaceutical logistics quality standards on a global basis. Logo: https://kyodonewsprwire.jp/img/202303013462-O1-7reh962D Image: NX-Pharma Global Quality Manualhttps://kyodonewsprwire.jp/prwfile/release/M103866/202303013462/_prw_PI2fl_yksd5VnD.jpg...
Servier Announces Partnership with QIAGEN to Develop New mIDH1 Companion Diagnostic Test to Support Servier’s Onco-hematology Portfolio
PARIS, March 9, 2023 /PRNewswire/ -- Servier, a global pharmaceutical group, today announced it has entered into a strategic partnership with QIAGEN, a leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life, to develop a companion diagnostic test...
GRAND LAUNCHING OF DNATEST.ID, A COMPREHENSIVE DNA TEST IN INDONESIA
JAKARTA, Indonesia, March 9, 2023 /PRNewswire/ -- PT Henindo Technologies Citra Mulia (HENINDO) together with PT Regene Artifisial Inteligen (REGENE) announce the launching of a comprehensive DNA TEST under the brand name of DNAtest.id. The event was attended by Prof. Dr. Amien Soebandrio, PhD, SpMK(K), Indonesian DNA Expert, Prof. Dr. dr. Yudi Ahmad Yudianto, SpFM(K), SH, M.K, Indonesian DNA Expert, ...
DIGITAL THERAPEUTICS STARTUP RESPIREE™ GAINS US FDA CLEARANCE FOR ITS RS001 CARDIO-RESPIRATORY WEARABLE
SINGAPORE, March 9, 2023 /PRNewswire/ -- Digital therapeutics startup Respiree has received the United States Food and Drug Administration's 510(k) clearance for its RS001 cardio-respiratory wearable. Illustrative Image of Respiree™’s RS001 Cardio-respiratory Wearable The RS001 is a chest wearable that measures respiration directly and can be used on patients suffering from cardio-pulmonary...
